Maria Marzilli

Maria Marzilli has over 15 years of industry experience across strategy, corporate development, and program and alliance management. Maria joined Q32 Bio from Agios Pharmaceuticals, where she was responsible for Portfolio Strategy and Alliance Management. In that role, she led cross-functional teams tasked with driving portfolio investment decisions and key assessments to inform the company’s overall strategy, business development activities and geographic footprint. She also managed the metabolic immuno-oncology partnership with Celgene, ensuring alignment on strategic and operational goals and priorities. Prior to Agios, Maria held roles of increasing responsibility at Biogen, beginning in Corporate Strategy and supporting the refinement and implementation of the company’s vision, and then moving to Global Market Access, where she helped support pricing and strategy decisions for portfolio programs as well as build out a world class Market Access team. Earlier in her career, she held roles at both Genzyme Corporation and Decision Resources. Maria received her B.A. in Biology from Harvard University and an M.P.H. in Health Services from the Boston University School of Public Health.